Home Global Blood Therapeutics latest biotech to double in debut
 

Keywords :   


Global Blood Therapeutics latest biotech to double in debut

2015-08-13 03:48:28| Biotech - Topix.net

Blood disorder drug developer Global Blood Therapeutics' shares more than doubled Wednesday as the company became the latest biotechnology company to get a powerful response from investors in its stock market debut. Global Blood Therapeutics Inc. says its treatment for sickle cell disease might stop red blood cells from becoming misshapen, treating the disease rather than its symptoms.

Tags: latest global double blood

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Boeing makes 38% pay rise offer in bid to end strike
01.11The house paints that promise much more than colour
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11How Japan's youngest CEO transformed Hello Kitty
31.10Unicharm to Expand in Africa
More »